Melissa Przeklasa Auth
Neurology with Special Qualifications in Child Neurology · Laguna Niguel, CANPI 1669679130
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Tris Pharma Inc at 44.2% of the total. 2025 is the largest year on record at $1,233, 3.7 times the $331 reported in 2019.
Across 179 payments — averaging $25.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$2K
- UCB, Inc.$908
- Ironshore Pharmaceuticals Inc.$457
- Supernus Pharmaceuticals, Inc.$210
- Aquestive Therapeutics, Inc.$189
- Neurelis, Inc.$134
- plus $608 from 11 others
What the payments were for
- Food & beverage$4,491100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 96 | $1,984 |
| UCB, Inc. | 20 | $908 |
| Ironshore Pharmaceuticals Inc. | 17 | $457 |
| Supernus Pharmaceuticals, Inc. | 14 | $210 |
| Aquestive Therapeutics, Inc. | 4 | $189 |
| Neurelis, Inc. | 2 | $134 |
| Eisai Inc. | 5 | $120 |
| GSK | 1 | $119 |
| Sunovion Pharmaceuticals Inc. | 4 | $83 |
| Corium, LLC | 4 | $73 |
| Neos Therapeutics, LP | 3 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Biomarin Pharmaceutical Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| SK Life Science, Inc. | 1 | $20 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$149
- Quillivant$139
- SYMPAZAN$125
- Briviact$125
- Nayzilam$124
- Fintepla$123
- BEXSERO$119
- VALTOCO$109
How this compares
$4,491 in reported general payments places this provider in the 70th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Other neurology with special qualifications in child neurology in Laguna Niguel
- Michael ChezSacramento$374K
- Allen BottOakland$372K
- Joseph SullivanSan Francisco$240K
- Ann SegerenStanford$172K
- Rajsekar RajaramanLos Angeles$134K
- Deborah HolderLos Angeles$130K
- Akash VirupakshaiahSan Francisco$94K
- Brittany PassiakSan Diego$90K
- Kevin ShapiroMadera$84K
- Terence SangerStanford$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.